Abstract
The eye has traditionally been regarded as an immune privileged site because inflammatory responses that would otherwise be detrimental to vision are modulated in the ocular environment. Numerous immunosuppressive mechanisms exist in the eye to accomplish this but it is clear that this status can be “broken” such as during infections and in the development of uveitis. Components of the innate immune system that sense pathogen components are present in ocular cells and activation results in the production of pro-inflammatory cytokines. Dendritic cells, which are critical for presenting antigen to the adaptive immune system are also present in the cornea, iris, and retina and can bind and process antigens and then traffic to the local draining lymph node or spleen resulting in antibody production, the generation of pathologic T-cells, or immunosuppressive regulatory T-cells. Innate and adaptive responses may similarly occur in response to the administration of ocular biologic drugs and viral gene delivery vectors, resulting in pathology that is immune-mediated and confounding drug development. This chapter reviews our current understanding of ocular immunology and disease mechanisms, known immunological pathology associated with drug development, comparative anatomical features of the eye, and regulatory aspects specific to ocular drug development and nonclinical testing strategies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akorn (2008) Akten Pharmacology Review – NDA 22221
Akorn (2014) Phenylephrine Hydrochloride Ophthalmic Solution Pharmacology Review – NDA 207926
Ambati J, Atkinson JP, Gelfand BD (2013) Immunology of age-related macular degeneration. Nat Rev Immunol 13(6):438–451. doi:10.1038/nri3459
Anderson JM (2012) Host response to long acting implants. In: Wright JC, Burgess DJ (eds) Advances in delivery science and technology. Vol long acting injections and implants. Springer (CRS). pp 25–55. doi:10.1007/978-1-4614-0554-2_3
Attar M, Brassard J, Kim A, Matsumoto S, Ramos M, Vangyi C (2013) Safety evaluation of ocular drugs. In: Faqi A (ed) A comprehnsive guide to toxicology in preclinical drug development. Academic, Waltham, MA, pp 567–617
Authier S, Vargas HM, Curtis MJ, Holbrook M, Pugsley MK (2013) Safety pharmacology investigations in toxicology studies: an industry survey. J Pharmacol Toxicol Methods 68(1):44–51
Barabino S, Chen Y, Chauhan S, Dana R (2012) Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res 31(3):271–285. doi:10.1016/j.preteyeres.2012.02.003
Barskey D (2006) Anatomy of the uveal tract. In: Jaeger EA, Tasman W (eds) Duane’s ophthalomology. Lippincott Williams & Wilkens, Philadelphia PA, pp 1–11
Bausch & Lomb (2005) Retisert (fluocinolone acetonide intravitreal implant) Pharmacology Review – NDA 021737
Besharse JC, Defoe DM (1998) Role of the retinal pigment epithelium in photoreceptor membrane turnover. In: Massey SC, Wolfensberger TW (eds) The retinal pigment epithelium. Oxford University Press, New York, p 152
Birke K, Lütjen-Drecoll E, Kerjaschki D, Birke MT (2010) Expression of podoplanin and other lymphatic markers in the human anterior eye segment. Invest Ophthalmol Vis Sci 51:344–354
Biros D (2008) Anterior chamber-associated immune deviation. Vet Clin North Am Small Anim Pract 38(2):309–321. doi:10.1016/j.cvsm.2007.12.006, vi-vii
Bishop PN (2000) Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res 19(3):323–344. doi:10.1016/S1350-9462(99)00016-6
Bishop PN (2014) Biochemistry. In: Sebag J (ed) Vitreous: in health and disease. Springer, New York, pp 3–20. doi:10.1007/978-1-4939-1086-1
Bobu C, Lahmam M, Vuillez P, Ouarour A, Hicks D (2008) Photoreceptor organisation and phenotypic characterization in retinas of two diurnal rodent species: potential use as experimental animal models for human vision research. Vision Res 48:424–432
Boycott B, Wassle H (1999) Parallel processing in the mammalian retina: the Proctor lecture. Invest Ophthalmol Vis Sci 40:1313–1327
Brandt CR (2014) Peptide therapeutics for treating ocular surface infections. J Ocul Pharmacol Ther 30(9):691–699. doi:10.1089/jop.2014.0089
Brandt CR, Knupfer PB, Boush GA, Gausas RE, Chandler JW (1990) In vivo induction of Ia expression in murine cornea after intravitreal injection of interferon-gamma. Invest Ophthalmol Vis Sci 31(11):2248–2253
Bryant-Hudson KM, Gurung HR, Zheng M, Carr DJJ (2014) Tumor necrosis factor alpha and interleukin-6 facilitate corneal lymphiangiogenesis in response to herpes simplex virus 1 infection. Nat Immunol 13:325–332
Buchen SY, Calogero D, Hilmantel G, Eydelman MB (2012) Rabbit ocular reactivity to bacterial endotoxin contained in aqueous solution and ophthalmic viscosurgical devices. Ophthalmology 119(7):e4–e10. doi:10.1016/j.ophtha.2012.04.006
Buelski PJ, Treacy G (2004) Predictive power of preclinical studies in animals for the immunogenicity of recombinant therapeutic proteins in humans. Curr Opin Mol Ther 6:10–16
Cain SA, Morgan A, Sherratt MJ, Ball SG, Shuttleworth CA, Kielty CM (2006) Proteomic analysis of fibrillin-rich microfibrils. Proteomics 6(1):111–122, doi:10.1002
Campbell M, Doyle SL (2013) An eye on the future of inflammasomes and drug development in AMD. J Mol Med 91(9):1059–1070. doi:10.1007/s00109-013-1050-0
Caspi RR (2006) Ocular autoimmunity: the price of privilege? Immunol Rev 213:23–35. doi:10.1111/j.1600-065X.2006.00439.x
Caspi RR (2010) A look at autoimmunity and inflammation in the eye. J Clin Invest 120(9):3073–3083. doi:10.1172/jci42440
Caspi RR (2014) Understanding autoimmunity in the eye: from animal models to novel therapies. Discov Med 17(93):155–162
Chang JH, McCluskey PJ, Wakefield D (2006) Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br J Ophthalmol 90(1):103–108. doi:10.1136/bjo.2005.072686
Chen HB, Yamabayashi S, Ou B, Tanaka Y, Ohno S, Tsukahara S (1997) Structure and composition of rat precorneal tear film. A study by an in vivo cryofixation. Invest Ophthalmol Vis Sci 38(2):381–387
Chen S, Zhou S, Zang K, Kong F, Liang D, Yan H (2014) CD73 expression in RPE cells is associated with the suppression of conventional CD4 cell proliferation. Exp Eye Res 127:26–36. doi:10.1016/j.exer.2014.05.008
Collin SP, Collin HB (1998) A comparative study of the corneal endothelium in vertebrates. Clin Exp Optom 81(6):245–254
Cook BE, Lucarelli MJ, Lemke BN, Dorzbach RK, Kaufman PL, Forresr L, Greene E, Gabelt BT (2002) Eyelid lymphatics II: a search for drainage patterns in the monkey and correlations with human lymphatics. Ophthal Plast Reconstr Surg 18(2):99–106
Crafoord S, Ghosh F, Sebag J (2014) Vitreous biochemistry and artificial vitreous. In: Sebag J (ed) Vitreous: in health and disease. Springer, New York, pp 81–92. doi:10.1007/978-1-4939-1086-1
Cursiefen C, Chen L, Saint-Geniez M, Hamrah P, Jin Y, Rashid S, Pytowski B, Persaud K, Wu Y, Streinlein JW, Dana R (2006) Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci USA 103(30):11405–11410, doi:10.1073
Davey MP, Rosenbaum JT (2000) The human leukocyte antigen complex and chronic ocular inflammatory disorders. Am J Ophthalmol 129(2):235–243
de Smet MD, Chan CC (2001) Regulation of ocular inflammation – what experimental and human studies have taught us. Prog Retin Eye Res 20(6):761–797
De Stefano ME, Mugnaini E (1997) Fine structure of the choroidal coat of the avian eye. Lymphatic vessels. Invest Ophthalmol Vis Sci 38(6):1241–1260
Denlinger JL, Balaz EA (2014) Hyaluronan and other carbohydrates in the vitreus. In: Sebag J (ed) Vitreous in health and disease. Springer, New York, pp 13–20
Desmet CJ, Ishii KJ (2012) Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat Rev Immunol 12(7):479–491. doi:10.1038/nri3247
Dickinson AJ, Gausa RE (2006) Orbital lymphatics: do they exist? Eye 20(10):1145–1148, doi:10.1038
Ding C, Parsa L, Nandoskar P, Zhao P, Wu K, Wang Y (2010) Duct system of the rabbit lacrimal gland: structural characteristics and role in lacrimal secretion. Invest Ophthalmol Vis Sci 51(6):2960–2967, doi:10.1167
EMEA (2006) Guideline on the limits of genotoxic impurities
Evans HE, de Lahunta A (2013) Miller’s anatomy of the dog, 4th edn. Elsevier, New York
FDA (2005) Guidance for industry. Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers
FDA (2015a) Guidance for industry and Food and Drug Administration staff, endotoxin testing recommendations for single-use intraocular ophthalmic devices
FDA (2015b) Guidance for industry. Scientific considerations in demonstrating biosimilarity to a reference product
FDA (2015c) Nonclinical safety evaluation of reformulated drug products and products intended for administration by an alternate route guidance for industry and review staff, good review practice
Forrester JV (2007) The eye: basic sciences in practice, 3rd edn. Saunders, Edinburgh, New York
Forrester JV, Xu H, Kuffova L, Dick AD, McMenamin PG (2010) Dendritic cell physiology and function in the eye. Immunol Rev 234(1):282–304. doi:10.1111/j.0105-2896.2009.00873.x
Forrester JV, Xu H, Lambe T, Cornall R (2008) Immune privilege or privileged immunity? Mucosal Immunol 1(5):372–381. doi:10.1038/mi.2008.27
Franchi L, Munoz-Planillo R, Nunez G (2012) Sensing and reacting to microbes through the inflammasomes. Nat Immunol 13(4):325–332. doi:10.1038/ni.2231
Fraunfelder FT, Fraunfelder FW, Chambers WA (2015) Drug-induced ocular side effects, 7th edn., Elsevier Saunders. ISBN 928-0-323-31984-3
Frazier KS, Engelhardt JA, Fant P, Guionaud S, Henry SP, Leach MW, Louden C, Scicchitano MS, Weaver JL, Zabka TS (2015) Scientific and regulatory policy committee points-to-consider paper*: Drug-induced vascular injury associated with nonsmall molecule therapeutics in preclinical development: Part I. Biotherapeutics. Toxicol Pathol. doi:10.1177/0192623315570340
Gao J, Liu RT, Cao S, Cui JZ, Wang A, To E, Matsubara JA (2015) NLRP3 inflammasome: activation and regulation in age-related macular degeneration. Mediators Inflamm 2015:690243. doi:10.1155/2015/690243
Gausas RE, Gonnering RS, Lemke BN, Dortzbach RK, Sherman DD (1999) Identification of human orbital lymphatics. Ophthal Plast Reconstr Surg 15(4):252–259
Gellat KN, Gilger BC, Kern TC (2014) Veterinary ophthalmology, 5th edn. Wiley-Blackwell, Hoboken, NJ
Genentech I (2006) FDA drug approval package: Lucentis (Ranibizumab) injection
Gery I, Chan C-C (2009) Mechanisms of uveitis. In: Yanoff M, Duker JS (eds) Ophthalmology, 3rd edn. Elsevier, China, pp 777–782
Ghiasi H, Cai S, Slanina S, Nesburn AB, Wechsler SL (1997) Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations. Invest Ophthalmol Vis Sci 38(6):1213–1221
Goody RJ, Hu W, Shafiee A, Struharik M, Bartels S, Lopez FJ, Lawrence MS (2011) Optimization of laser-induced choroidal neovascularization in African green monkeys. Exp Eye Res 92(6):464–472. doi:10.1016/j.exer.2011.03.006
Gregerson DS, Heuss ND, Lew KL, McPherson SW, Ferrington DA (2007) Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy. Invest Ophthalmol Vis Sci 48(10):4654–4663. doi:10.1167/iovs.07-0286
Grossniklaus HE, Kang SJ, Berglin L (2010) Animal models of choroidal and retinal neovascularization. Prog Retin Eye Res 29(6):500–519. doi:10.1016/j.preteyeres.2010.05.003
Guadana R, Ananthula HK, Parenky A, Mitra AK (2010) Ocular drug delivery. AAPS 12(3):348–360
Gusev AM (1964) Lymph vessels of human conjunctiva. Fed Proc Transl Suppl 23:109901102
Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20(6):705–732
Halfter W, Sebag J, Cunningham ET Jr (2014) Vitreoretinal interface and inner limiting membrane. In: Sebag J (ed) Vitreous: in health and disease. Springer, New York, pp 165–191. doi:10.1007/978-1-4939-1086-1
Hamel CP, Detrick B, Hooks JJ (1990) Evaluation of Ia expression in rat ocular tissues following inoculation with interferon-gamma. Exp Eye Res 50(2):173–182
Hansen TH, Bouvier M (2009) MHC class I antigen presentation: learning from viral evasion strategies. Nat Rev Immunol 9(7):503–513. doi:10.1038/nri2575
Harris A, Bingaman D, Ciulla TA, Martin B (2006) Retinal and choroidal blood flow in health and disease. In: Ryan SJ (ed) Retina. Elsevier Mosby, China, pp 83–102
Hayreh SS (1974) Recent advances in fluorescein fundus angiography. Br J Ophthalmol 58:391–412
Hazlett L, Wu M (2011) Defensins in innate immunity. Cell Tissue Res 343(1):175–188. doi:10.1007/s00441-010-1022-4
Henao-Mejia J, Elinav E, Strowig T, Flavell RA (2012) Inflammasomes: far beyond inflammation. Nat Immunol 13(4):321–324. doi:10.1038/ni.2257
Heuss ND, Lehmann U, Norbury CC, McPherson SW, Gregerson DS (2012) Local activation of dendritic cells alters the pathogenesis of autoimmune disease in the retina. J Immunol 188(3):1191–1200. doi:10.4049/jimmunol.1101621
Holtkamp GM, Kijlstra A, Peek R, de Vos AF (2001) Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes. Prog Retin Eye Res 20(1):29–48
Huml RA, Rich C, Chance K (2009) Key challenges to US topical ocular drug development. Regulatory Focus 14:47–52
Hutala A, Salminen L, Tahti H, Uusitalo H (2008) Corneal models for the toxicity testing of drugs and drug releasing materials. In: Ashammakhi N (ed) Topics in multifunctional biomaterials and devices, biomaterials and tissue engineering group
ICH-M3(R2) (2010) ICH harmonized tripartite guideline, guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals
ICH-M7 (2015) Guidance for industry, Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk
ICH-Q3A(R2) (2006) ICH harmonized tripartite guideline, impurities in new drug substances
ICH-Q3B(R2) (2006) ICH Harmonized tripartite guideline, impurities in new drug products
ICH-S1A (1995) ICH harmonized tripartite guideline, guideline on the need for carcinogenicity studies of pharmaceuticals
ICH-S2(R1) (2011) ICH harmonized tripartite guideline, guideline on genotoxicity testing and data interpretation for pharmaceuticals intended for human use
ICH-S6(R1) (2011) ICH Harmonized tripartite guideline, guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals
ICH-S7A (2000) ICH harmonized tripartite guideline, safety pharmacology studies for human pharmaceuticals
Industry. I-DGf (2008) Genotoxic and carcinogenic impurities in drug substances and products: recommended approaches
Ishida K, Panjwani N, Cao Z, Streilein JW (2003) Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms. Ocul Immunol Inflamm 11(2):91–105
ISO-15798:2013 (2013) ISO-15798:2013 Ophthalmic implants-ophthalmic viscosurgical devices
Izazola-Conde C, Zamora-de la Cruz D, Tenorio-Guajardo G (2011) Ocular and systemic adverse effects of ophthalmic and non ophthalmic medications. Proc West Pharmacol Soc 54:69–72
Jensen S, Thomsen AR (2012) Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion. J Virol 86(6):2900–2910. doi:10.1128/JVI.05738-11
Johnson DH (2005) Trabecular meshwork and uveoscleral outflow models. J Glaucoma 14(4):308–310
Joshi M, Agrawal S, Christoforidis JB (2013) Inflammatory mechanisms of idiopathic epiretinal membrane formation. Mediators Inflamm 2013:192582. doi:10.1155/2013/192582
Juliusson B, Bergstrom A, Rohlich P, Ehinger B, van Veen T, Szel A (1994) Complementary cone fields of the rabbit retina. Invest Ophthalmol Vis Sci 35:811–818
Kaestel CG, Jorgensen A, Nielsen M, Eriksen KW, Odum N, Holst Nissen M, Ropke C (2002) Human retinal pigment epithelial cells inhibit proliferation and IL2R expression of activated T cells. Exp Eye Res 74(5):627–637. doi:10.1006/exer.2002.1183
Kaplan HJ, Streilein JW, Stevens TR (1975) Transplantation immunology of the anterior chamber of the eye. II Immune response to allogeneic cells. J Immunol 115(3):805–810
Karlsetter M, Scholz R, Rutar M, Wong WT, Provis JM, Langman T (2015) Retinal Microglial; just bystander or target for therapy? Prog Retin Eye Res 45:30–57
Kaufman J (2013) Antigen processing and presentation: evolution from a bird's eye view. Mol Immunol 55(2):159–161. doi:10.1016/j.molimm.2012.10.030
Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11(5):373–384. doi:10.1038/ni.1863
Keenan CM, Baker J, Bradley A, Goodman DG, Harada T, Herbert R, Kaufmann W, Kellner R, Mahler B, Meseck E, Nolte T, Rittinghausen S, Vahle J, Yoshizawa K (2015) International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): progress to date and future plans. Toxicol Pathol 43(5):730–732. doi:10.1177/0192623314560031
Kiel JW, Hollingsworth M, Rao R, Chen M, Reitsmer HA (2011) Ciliary blood flow and aqueous humor production. Prog Retin Eye Res 30(1):1–17, doi:10.1016
Kijlstra A (1994) The role of cytokines in ocular inflammation. Br J Ophthalmol 78(12):885–886
Kita T, Sakamoto T, Ishibashi T (2014) Hyalocytes: essential vitreous cells in vitreoretinal health and disease. In: Sebag J (ed) Vitreous: in health and disease. Springer, New York, pp 151–164. doi:10.1007/978-1-4939-1086-1
Kleinman ME, Ambati J (2012) A window to innate neuroimmunity: toll-like receptor-mediated cell responses in the retina. Adv Exp Med Biol 723:3–9. doi:10.1007/978-1-4614-0631-0_1
Knickelbein JE, Buela KA, Hendricks RL (2014) Antigen-presenting cells are stratified within normal human corneas and are rapidly mobilized during ex vivo viral infection. Invest Ophthalmol Vis Sci 55(2):1118–1123. doi:10.1167/iovs.13-13523
Kohno RI, Hata Y, Kawahara S, Kita T, Arita R, Mochizuki Y, Aiello LP, Ishibashi T (2009) Possible contribution of hyalocytes to idiopathic epiretinal membrane formation and its contraction. Br J Ophthalmol 93(8):1020–1026. doi:10.1136/bjo.2008.155069
Kolar SS, McDermott AM (2011) Role of host-defence peptides in eye diseases. Cell Mol Life Sci 68(13):2201–2213. doi:10.1007/s00018-011-0713-7
Krebs W, Krebs IP (1988) Ultrastructural evidence for lymphatic capillaries in the primate choroid. Arch Ophthalmol 106(11):1615–1616
Kumar A, Shamsuddin N (2012) Retinal Muller glia initiate innate response to infectious stimuli via toll-like receptor signaling. PLoS One 7(1):e29830. doi:10.1371/journal.pone.0029830
Kumar A, Yu FS (2006) Toll-like receptors and corneal innate immunity. Curr Mol Med 6(3):327–337
Kumar MV, Nagineni CN, Chin MS, Hooks JJ, Detrick B (2004) Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells. J Neuroimmunol 153(1-2):7–15. doi:10.1016/j.jneuroim.2004.04.018
Lambiase A, Micera A, Sacchetti M, Mantelli F, Bonini S (2011) Toll-like receptors in ocular surface diseases: overview and new findings. Clin Sci (Lond) 120(10):441–450. doi:10.1042/CS20100425
Leach MW (2013a) Regulatory forum opinion piece: differences between protein-based biologic products (biotherapeutics) and chemical entities (small molecules) of relevance to the toxicologic pathologist. Toxicol Pathol 41(1):128–136. doi:10.1177/0192623312451371
Leach MW (2013b) Regulatory forum opinion piece: differences between protein-based biologic products (biotherapeutics) and chemical entities (small molecules) of relevance to the toxicologic pathologist. Toxicol Pathol 41:128–136
Leach MW, Rottman JB, Hock MB, Finco D, Rojko JL, Beyer JC (2014) Immunogenicity/hypersensitivity of biologics. Toxicol Pathol 42(1):293–300. doi:10.1177/0192623313510987
Lehmann U, Heuss ND, McPherson SW, Roehrich H, Gregerson DS (2010) Dendritic cells are early responders to retinal injury. Neurobiol Dis 40(1):177–184. doi:10.1016/j.nbd.2010.05.022
Lin P, Menda S, de Juan EJ (2014) Priniciples and practice of intravitreal application of drugs. In: Sebag J (ed) Vitreous: In health and disease. Springer, New York, pp 509–521, DOI 10.1007/978-1-4939-1086-1_30
Liversidge J, Grabowski P, Ralston S, Benjamin N, Forrester JV (1994) Rat retinal pigment epithelial cells express an inducible form of nitric oxide synthase and produce nitric oxide in response to inflammatory cytokines and activated T cells. Immunology 83(3):404–409
Liversidge J, McKay D, Mullen G, Forrester JV (1993) Retinal pigment epithelial cells modulate lymphocyte function at the blood-retina barrier by autocrine PGE2 and membrane-bound mechanisms. Cell Immunol 149(2):315–330. doi:10.1006/cimm.1993.1158
Lutty GA, Merges C, Threkeld AB, Crone S, McLeod DS (1993) Heterogeneity in localization of isoforms of TGF-beta in human retina, vitreous, and choroid. Invest Ophthalmol Vis Sci 34:477–487
Mai K, Chui JJ, Di Girolamo N, McCluskey PJ, Wakefield D (2014) Role of toll-like receptors in human iris pigment epithelial cells and their response to pathogen-associated molecular patterns. J Inflamm 11:20. doi:10.1186/1476-9255-11-20
Mann PC, Vahle J, Keenan CM, Baker JF, Bradley AE, Goodman DG, Harada T, Herbert R, Kaufmann W, Kellner R, Nolte T, Rittinghausen S, Tanaka T (2012) International harmonization of toxicologic pathology nomenclature: an overview and review of basic principles. Toxicol Pathol 40(4 Suppl):7S–13S
Masli S, Vega JL (2011) Ocular immune privilege sites. In: Cuturi MC, Anegon I (eds) Suppression and regulation of immune responses, vol 677, Methods in molecular biology. Springer, New York, pp 449–458. doi:10.1007/978-1-60761-869-0
Massey SC (2006) Functional anatomy of the mammalian retina. In: Ryan SJ (ed) Retina. Elsevier Mosby, China, pp 43–82
Matsumoto B, Blanks JC, Ryan SJ (1984) Topographic variations in the rabbit and primate internal limiting membrane. Invest Ophthalmol Vis Sci 25(1):71–82
May AC (2008) Comparative anatomy of the optic nerve head and inner retina in non-primate animal models used for glaucoma research. Open Ophthalmol J 2:94–101. doi:10.2174/1874364100802010094
McDermott AM (2013) Antimicrobial compounds in tears. Exp Eye Res 117:53–61. doi:10.1016/j.exer.2013.07.014
McLellan GJ, Teixeira LB (2015) Feline glaucoma. Vet Clin North Am Small Anim Pract 445(6):1307–1333, doi:10.1016
McPherson SW, Heuss ND, Pierson MJ, Gregerson DS (2014) Retinal antigen-specific regulatory T cells protect against spontaneous and induced autoimmunity and require local dendritic cells. J Neuroinflammation 11:205. doi:10.1186/s12974-014-0205-4
Medawar PB (1948) Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29(1):58–69
Meek B, Speijer D, de Jong PT, de Smet MD, Peek R (2003) The ocular humoral immune response in health and disease. Prog Retin Eye Res 22(3):391–415
Mehta S, Zhang L, Grossniklaus HE (2014) Cell proliferation at the vitreoretinal interface in proliferative vitreoretinopathy and related disorders. In: Sebag J (ed) Vitreous: in health and disease. Springer, New York, pp 395–405. doi:10.1007/978-1-4939-1086-1
Mo JS, Streilein JW (2001) Immune privilege persists in eyes with extreme inflammation induced by intravitreal LPS. Eur J Immunol 31(12):3806–3815. doi:10.1002/1521-4141(200112)31:12<3806::AID-IMMU3806>3.0.CO;2-M
Mochizuki M (2010) Regional immunity of the eye. Acta Ophthalmol 88(3):292–299. doi:10.1111/j.1755-3768.2009.01757.x
Mochizuki M, Sugita S, Kamoi K (2013) Immunological homeostasis of the eye. Prog Retin Eye Res 33:10–27. doi:10.1016/j.preteyeres.2012.10.002
Mowat FM, Peterson-Jones SM, Williamson H, Williams DL, Luthert PJ, Ali RR, Bainbridge JW (2008) Topographical characterization of cone photoreceptors and the area centralis of the canine retina. Mol Vis 14:2518–2527
Munro IC, Renwick AG, Danielewska-Nikiel B (2008) The Threshold of Toxicological Concerns (TTC) in risk assessment. Toxicol Lett 180(2):151–156
Novack GD (2009) Ophthalmic drug delivery: development and regulatory considerations. Clin Pharmacol Ther 85:539–543
Nussenblatt RB, Calogero D, Buchen SY, Leder HA, Goodkin M, Eydelman MB (2012) Rabbit intraocular reactivity to endotoxin measured by slit-lamp biomicroscopy and laser flare photometry. Ophthalmology 119(7):e19–e23. doi:10.1016/j.ophtha.2012.04.004
Nussenblatt RB, Lee RW, Chew E, Wei L, Liu B, Sen HN, Dick AD, Ferris FL (2014) Immune responses in age-related macular degeneration and a possible long-term therapeutic strategy for prevention. Am J Ophthalmol 158(1):5–11. doi:10.1016/j.ajo.2014.03.014, e12
OECD (ed) (2013) OECD Guidelines, Test No. 437: Bovine corneal opacity and permeability test method for identifying i) Chemicals inducing serious eye damage and ii) Chemicals not requiring classification for eye irritation or serious eye damage. OECD Publishing, Paris
Ollivier FJ, Samuelson DA, Brooks DE, Lewis PA, Kallberg ME, Kaufman PL, Komáromy AM (2004) Comparative morphology of the tapetum lucidum (among selected species). Vet Ophthalmol 7(1):11–22
Owen JA, Punt J, Stranford SA, Jones PP (2013a) Kuby immunology, 7th edn. WH Freeman & Co, New York, pp 141–182
Owen JA, Punt J, Stranford SA, Jones PP (2013b) Kuby immunology, 7th edn. WH Freeman & Co, New York, pp 261–296
Owen JA, Punt J, Stranford SA, Jones PP (2013c) Kuby immunology, 7th edn. WH Freeman & Co, New York, pp 1–24
Park PJ, Chang M, Garg N, Zhu J, Chang JH, Shukla D (2015) Corneal lymphangiogenesis in herpetic stromal keratitis. Surv Ophthalmol 60(1):60–71. doi:10.1016/j.survophthal.2014.06.001
Paulsen FP, Berry MS (2006) Mucins and TFF peptides of the tear film and lacrimal apparatus. Prog Histochem Cytochem 41(1):1–53, doi:10.1016
Payne AP (1994) The harderian gland: a tercentennial review. J Anat 185(Pt 1):1–49
Pearlman E, Johnson A, Adhikary G, Sun Y, Chinnery HR, Fox T, Kester M, McMenamin PG (2008) Toll-like receptors at the ocular surface. Ocul Surf 6(3):108–116
Pearlman E, Sun Y, Roy S, Karmakar M, Hise AG, Szczotka-Flynn L, Ghannoum M, Chinnery HR, McMenamin PG, Rietsch A (2013) Host defense at the ocular surface. Int Rev Immunol 32(1):4–18. doi:10.3109/08830185.2012.749400
Peczon BD, Peczon JD, Cintron C, Hudson BG (1980) Changes in chemical composition of anterior lens capsules of cataractous human eyes as a function of age. Exp Eye Res 30(2):155–165
Peichl L (2005) Diversity of mammalian photoreceptor properties: adaptations to habitat and lifestyle? Anat Rec A 287A:1001–1012
Penedones A, Mendes D, Alves C, Marques FB (2015) Drug-induced ocular adverse reactions: review of the safety alerts issued during the last decade. J Ocular Pharmacol Ther 31(5):258–268
Perez VL, Saeed AM, Tan Y, Urbieta M, Cruz-Guilloty F (2013) The eye: a window to the soul of the immune system. J Autoimmun 45:7–14. doi:10.1016/j.jaut.2013.06.011
Ponce R, Abad L, Amaravadi L, Gelzleichter T, Gore E, Green J, Gupta S, Herzyk D, Hurst C, Ivens IA, Kawabata T, Maier C, Mounho B, Rup B, Shankar G, Smith H, Thomas P, Wierda D (2009) Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies. Regul Toxicol Pharmacol 54(2):164–182
Prince JH, McConnell DG (1964) Retina and optic nerve. In: Prince JH (ed) The rabbit in eye research. Charles C Thomas, Springville, pp 385–448
Qiao H, Hisatomi T, Sonoda KH, Kura S, Sassa Y, Kinoshita S, Nakamura T, Sakamoto T, Ishibashi T (2005) The characterisation of hyalocytes: the origin, phenotype, and turnover. Br J Ophthalmol 89(4):513–517, doi:10.1136
Rada JA, Shelton S, Norton TT (2006) The sclera and myopia. Exp Eye Res 82(2):185–200, doi:10.1016
Rathinam VA, Vanaja SK, Fitzgerald KA (2012) Regulation of inflammasome signaling. Nat Immunol 13(4):333–342. doi:10.1038/ni.2237
Redfern RL, McDermott AM (2010) Toll-like receptors in ocular surface disease. Exp Eye Res 90(6):679–687. doi:10.1016/j.exer.2010.03.012
Regeneron Pharmaceuticals I (2011) FDA Drug Approval Package: Eylea (aflibercept) injection
Reikine S, Nguyen JB, Modis Y (2014) Pattern recognition and signaling mechanisms of RIG-I and MDA5. Front Immunol 5:342. doi:10.3389/fimmu.2014.00342
Remtulla S, Hallett PE (1985) A schematic eye for the mouse, and comparisons with the rat. Vision Res 25(1):21–31
Riordan-Eva P (2011) Anatomy & embryology of the eye. In: Riordan-Eva P, Cunningham ET (eds) Vaughan and Asbury's General Ophthalmology. 18 edn
Rocha G, Baines MG, Deschenes J (1992) The immunology of the eye and its systemic interactions. Crit Rev Immunol 12(3-4):81–100
Rojko JL, Evans MG, Price SA, Han B, Waine G, DeWitte M, Haynes J, Freimark B, Martin P, Raymond JT, Evering W, Rebelatto MC, Schenck E, Horvath C (2014) Formation, clearance, deposition, pathogenicity, and identification of biopharmaceutical-related immune complexes: review and case studies. Toxicol Pathol 42(4):725–764. doi:10.1177/0192623314526475
Rowe AM, St Leger AJ, Jeon S, Dhaliwal DK, Knickelbein JE, Hendricks RL (2013) Herpes keratitis. Prog Retin Eye Res 32:88–101. doi:10.1016/j.preteyeres.2012.08.002
Saidi T, Mbarek S, Chaouacha-Chekir RB, Hicks D (2011) Diurnal rodents as animal models of human central vision: characterisation of the retina of the sand rat Psammomys obsesus. Graefes Arch Clin Exp Ophthalmol 249:1029–1037
Sakamoto T, Ishibashi T (2011) Hyalocytes: essential cells of the vitreous cavity in vitreoretinal pathophysiology? Retina 331:222–228
Samuelson DA (2007) Ophthalmic anatomy. In: Gelatt KN (ed) Veterinary ophthalmology. Blackwell, Ames, pp 37–148
Samuelson DA, Streit A (2012) Microanatomy of the anterior uveoscleral outflow pathway in normal and primary open-angle glaucomatous dogs. Vet Ophthalmol 15(Suppl 1):47–53, doi:10.1111
Schafer KA, Render JA (2013) Toxicologic pathology of the eye: alterations of the lens and posterior segment. In: Weir AB, Collins MJ (eds) Assessing ocular toxicology in laboratory animals. Humana, New York, pp 219–257
Schroedl F, Brehmer A, Neuhuber WL, Kruse FE, May CA, Cursiefen C (2008) The normal human choroid is endowed with a significant number of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1)-positive macrophages. Invest Ophthalmol Vis Sci 49(12):5222–5228, doi:10.1167
Schumann RG, Eibl KH, Zhao F, Scheerbaum M, Scheler R, Schaumberger MM, Wehnes H, Walch AK, Haritoglou C, Kampik A, Gandorfer A (2011) Immunocytochemical and ultrastructural evidence of glial cells and hyalocytes in internal limiting membrane specimens of idiopathic macular holes. Invest Ophthalmol Vis Sci 52(11):7822–7834. doi:10.1167/iovs.11-7514
Sebag J, Buckingham B, Charles MA, Reiser K (1992) Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch Ophthalmol 110(10):1472–1476
Short BG (2008) Safety evaluation of ocular drug delivery formulations: techniques and practical considerations. Toxicol Pathol 36:49–62
Silva NC, Sarmento B, Pintado M (2013) The importance of antimicrobial peptides and their potential for therapeutic use in ophthalmology. Int J Antimicrob Agents 41(1):5–10. doi:10.1016/j.ijantimicag.2012.07.020
Silver PB, Horai R, Chen J, Jittayasothorn Y, Chan CC, Villasmil R, Kesen MR, Caspi RR (2015) Retina-specific T regulatory cells bring about resolution and maintain remission of autoimmune uveitis. J Immunol 194(7):3011–3019. doi:10.4049/jimmunol.1402650
Smith RS (2002) Systematic evaluation of the mouse eye: anatomy, pathology, and biomethods. CRC, Boca Raton, FL
Sonoda KH, Sakamoto T, Qiao H, Hisatomi T, Oshima T, Tsutsumi-Miyahara C, Exley M, Balk SP, Taniguchi M, Ishibashi T (2005) The analysis of systemic tolerance elicited by antigen inoculation into the vitreous cavity: vitreous cavity-associated immune deviation. Immunology 116(3):390–399
Strauss O (2005) The retinal pigment epithelium in visual function. Phys Rev 85:845–881
Streilein JW (1990) Anterior chamber associated immune deviation: the privilege of immunity in the eye. Surv Ophthalmol 35(1):67–73
Streilein JW (2003) Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 3(11):879–889. doi:10.1038/nri1224
Streit T, Miller PE, Ellison B, Thackenberry EA, Schuetz C, Sorentag P, Farmin C, Christian BJ, Bantsoer V (2015) Determination of a No Observable Effect Level (NOEL) for endotoxin following a single intravitreal administration to male dutch belted rabbits. In: ARVO, Denver, Colorado, 2015
Thomasy SM, Eaton JS, Timberlake MJ, Miller PE, Matsumoto S, Murphy CL (2016) Species differences in the geometry of the anterior segment differentially affect anterior chamber cell scoring systems in laboratory animals. J Ocul Pharmacol Ther 32(1):28–37
Torres PF, Kijlstra A (2001) The role of cytokines in corneal immunopathology. Ocul Immunol Inflamm 9(1):9–24
Tozer K, Johnson MW, Sebag J (2014) Vitreous aging and posterior vitreous detachment. In: Sebag J (ed) Vitreous: in health and disease. Springer, New York, pp 131–150. doi:10.1007/978-1-4939-1086-1
Treacy G, Martin B (2008) Preclinical safety evaluation of monoclonal antibodies. In: Cavagnaro JA (ed) Preclinical safety evaluation of biopharmaceuticals: a science-based approach to facilitating clinical trials. John Wiley, Hoboken, NJ, pp 587–599
Tripathi B, Ashton N (1971) Vaso-glial connections in the rabbit retina. Br J Ophthalmol 55:1–11
Ueta M, Kawai T, Yokoi N, Akira S, Kinoshita S (2011) Contribution of IPS-1 to polyI:C-induced cytokine production in conjunctival epithelial cells. Biochem Biophys Res Commun 404(1):419–423. doi:10.1016/j.bbrc.2010.11.136
Ueta M, Kinoshita S (2012) Ocular surface inflammation is regulated by innate immunity. Prog Retin Eye Res 31(6):551–575. doi:10.1016/j.preteyeres.2012.05.003
Van Dooremaal JC (1873) Die entwicklung der in fremden grund versetzten lebenden gewaba. Albrecht Von Graefes Arch Klin Exp Ophthalmol 19:358
Vanaja SK, Rathinam VA, Fitzgerald KA (2015) Mechanisms of inflammasome activation: recent advances and novel insights. Trends Cell Biol 25(5):308–315. doi:10.1016/j.tcb.2014.12.009
Verthelyi D, Wang V (2010) Trace levels of innate immune response modulating impurities (IIRMIs) synergize to break tolerance to therapeutic proteins. PLoS One 5(12):e15252. doi:10.1371/journal.pone.0015252
Wallace CA, Moir G, Malone DF, Duncan L, Devarajan G, Crane IJ (2013) Regulation of T-lymphocyte CCL3 and CCL4 production by retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 54(1):722–730. doi:10.1167/iovs.12-10602
Walls GL (1942) The vertebrate eye and its adaptive radiation, 1st edn. Cranbrook Institute of Science, New York
Weir A, Collins M (2013) Assessing ocular toxicology in laboratory animals. Humana, New York
Wilkerson CL, Syed NA, Fisher MR, Robinson NL, Wallow IH, Albert DM (1996) Melanocytes and iris color. Light microscopic findings. Arch Ophthalmol 114:437–442
Wilson SL, Ahearne M, Hopkinson A (2015) An overview of current techniques for ocular toxicity testing. Toxicology 327:32–46
Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5(7):730–737. doi:10.1038/ni1087
Yücel YH, Johnston MG, Ly T, Patel M, Drake B, Gümüş E, Fraenkl SA, Moore S, Tobbia D, Armstrong D, Horvath E, Gupta N (2009) Identification of lymphatics in the ciliary body of the human eye: a novel “uveolymphatic” outflow pathway. Exp Eye Res 89:810–819, doi:10.1016
Zhao F, Gandorfer A, Haritoglou C, Scheler R, Schaumberger MM, Kampik A, Schumann RG (2013) Epiretinal cell proliferation in macular pucker and vitreomacular traction syndrome: analysis of flat-mounted internal limiting membrane specimens. Retina 33(1):77–88. doi:10.1097/IAE.0b013e3182602087
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Ramos, M.F., Teixeira, L., Brandt, C.R., Auyeung-Kim, D. (2017). Ocular Immunopathology. In: Parker, G. (eds) Immunopathology in Toxicology and Drug Development. Molecular and Integrative Toxicology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-47385-7_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-47385-7_14
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-47384-0
Online ISBN: 978-3-319-47385-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)